The role of estrogen receptors and their signaling across psychiatric disorders

WJ Hwang, TY Lee, NS Kim, JS Kwon - International journal of molecular …, 2020 - mdpi.com
Increasing evidence suggests estrogen and estrogen signaling pathway disturbances
across psychiatric disorders. Estrogens are not only crucial in sexual maturation and …

An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis

N Çakici, NJM Van Beveren, G Judge-Hundal… - Psychological …, 2019 - cambridge.org
BackgroundAccumulating evidence shows that a propensity towards a pro-inflammatory
status in the brain plays an important role in schizophrenia. Anti-inflammatory drugs might …

Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders–A comprehensive systematic review and meta-analysis

R Jeppesen, RHB Christensen, EMJ Pedersen… - Brain, behavior, and …, 2020 - Elsevier
Objective Antipsychotic effects of immunomodulating drugs have been suggested; however,
a thorough, comprehensive meta-analysis on the effect and safety of anti-inflammatory add …

Sex differences in schizophrenia, bipolar disorder, and post‐traumatic stress disorder: Are gonadal hormones the link?

A Gogos, LJ Ney, N Seymour… - British Journal of …, 2019 - Wiley Online Library
In this review, we describe the sex differences in prevalence, onset, symptom profiles, and
disease outcome that are evident in schizophrenia, bipolar disorder, and post‐traumatic …

Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology

TRE Barnes, R Drake, C Paton… - Journal of …, 2020 - journals.sagepub.com
These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Adjunctive use of anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials

M Cho, TY Lee, YB Kwak, YB Yoon… - Australian & New …, 2019 - journals.sagepub.com
Objective: Recent evidence suggests that adjuvant anti-inflammatory agents could improve
the symptoms of patients with schizophrenia. However, the effects of the adjuvant anti …

Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research

J Grigg, R Worsley, C Thew, C Gurvich, N Thomas… - …, 2017 - Springer
Rationale Hyperprolactinemia is a highly prevalent adverse effect of many antipsychotic
agents, with potentially serious health consequences. Several guidelines have been …

Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses

A Riecher-Rössler - The Lancet Psychiatry, 2017 - thelancet.com
Interest is growing in the potential effect of gonadal hormones, prolactin, and the
hypothalamic–pituitary–gonadal axis in schizophrenic psychoses. Many studies from …

Hormonal agents for the treatment of depression associated with the menopause

M Herson, J Kulkarni - Drugs & Aging, 2022 - Springer
Perimenopause marks the transition from a woman's reproductive stage to menopause.
Usually occurring between 42 and 52 years of age, it is determined clinically by the onset of …

The direct and long-term effects of raloxifene as adjunctive treatment for schizophrenia-spectrum disorders: a double-blind, randomized clinical trial

BA Brand, JN De Boer, MC Marcelis… - Schizophrenia …, 2023 - academic.oup.com
Background and hypothesis Several studies suggest that raloxifene, a selective estrogen
receptor modulator, improves symptoms and cognition in post-menopausal women with …